Association of donor-specific microchimerism with graft dysfunction in kidney transplant patients.

[1]  K. Wood,et al.  Tolerance in renal transplantation: is mixed chimerism the missing link? , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  C. Fourtounas,et al.  Microchimerism in peripheral blood and urine in renal transplant recipients: preliminary results. , 2008, Transplantation proceedings.

[3]  E. Engleman,et al.  Tolerance and chimerism after renal and hematopoietic-cell transplantation. , 2008, The New England journal of medicine.

[4]  B. Nikbin,et al.  MICROCHIMERISM AND RENAL TRANSPLANTATION:DOUBT STILL PERSISTS , 2007 .

[5]  D. Latinne,et al.  The immunological monitoring of alloreactive responses in liver transplant recipients: A review , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  L. Shields,et al.  Chimerism analysis by sex determining region Y (SRY) and major histocompatibility complex markers in non-human primates using quantitative real-time polymerase chain reaction. , 2005, Tissue antigens.

[7]  D. Furst,et al.  Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. , 2004, Arthritis and rheumatism.

[8]  C. Poremba,et al.  Evaluation of host stem cell-derived cardiac myocytes in consecutive biopsies in long-term cardiac transplant patients. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  M. Karim,et al.  The role of the graft in establishing tolerance. , 2002, Frontiers in bioscience : a journal and virtual library.

[10]  C. Ricordi,et al.  Real-time sequence-specific primer polymerase chain reaction amplification of HLA class II alleles: a novel approach to analyze microchimerism. , 2002, Transplantation.

[11]  Biggi Branke,et al.  Quantitative polymerase chain reaction-based assay with fluorogenic Y-chromosome specific probes to measure bone marrow chimerism in mice. , 2002, Journal of immunological methods.

[12]  W. Holzgreve,et al.  Cell‐Free DNA in Urine , 2001 .

[13]  N. Kröger,et al.  Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. , 2001, Journal of hematotherapy & stem cell research.

[14]  T. Lion,et al.  Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers , 2001, Leukemia.

[15]  J. Wang,et al.  The study of peripheral blood microchimerism in kidney transplantation. , 2001, Transplantation proceedings.

[16]  L. Es,et al.  Endothelial cell chimerism after renal transplantation and vascular rejection , 2001, The Lancet.

[17]  E. Engleman,et al.  Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. , 2000, Transplantation.

[18]  Y. Lo,et al.  Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. , 1999, Clinical chemistry.

[19]  T. Starzl,et al.  Antigen localization and migration in immunity and tolerance. , 1998, The New England journal of medicine.

[20]  R. Blasczyk,et al.  Fluorotyping of HLA-A by sequence-specific priming and fluorogenic probing. , 1998, Tissue antigens.

[21]  R. Wassmuth,et al.  Microchimerism after liver transplantation: prevalence and methodological aspects of detection. , 1998, Transplantation.

[22]  N. M. Hjelm,et al.  Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients , 1998, The Lancet.

[23]  T K Lau,et al.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.

[24]  B. Portmann,et al.  Defining the outcome of immunosuppression withdrawal after liver transplantation , 1998, Hepatology.

[25]  C. O’Farrelly,et al.  Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance , 1997, Hepatology.

[26]  T. Howard,et al.  Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. , 1997, Transplantation.

[27]  C. Larsen,et al.  Microchimerism and rejection in clinical transplantation , 1997, The Lancet.

[28]  T. Howard,et al.  Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. , 1996, Transplantation.

[29]  H. Schlitt,et al.  Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. , 1996, Transplantation.

[30]  M. Andrien,et al.  Detection of blood chimerism after lung and heart-lung transplantation. The superiority of nested as compared with standard polymerase chain reaction amplification. , 1994, Transplantation.

[31]  C. Bodemer,et al.  Peripheral microchimerism in long-term cadaveric-kidney allograft recipients , 1994, The Lancet.

[32]  M. Karck,et al.  Patterns of donor-type microchimerism after heart transplantation , 1994, The Lancet.

[33]  H. Schlitt,et al.  Donor-type microchimerism associated with graft rejection eight years after liver transplantation. , 1994, The New England journal of medicine.

[34]  T. Starzl,et al.  CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION , 1993, Transplantation.

[35]  T. Starzl,et al.  Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance , 1993, Hepatology.

[36]  T. Starzl,et al.  Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction. , 1993, Transplantation proceedings.

[37]  T. Starzl,et al.  Cell migration, chimerism, and graft acceptance , 1992, The Lancet.

[38]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[39]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[40]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.